Stay updated on Bardoxolone in CTD-Associated Pulmonary Arterial Hypertension Clinical Trial
Sign up to get notified when there's something new on the Bardoxolone in CTD-Associated Pulmonary Arterial Hypertension Clinical Trial page.

Latest updates to the Bardoxolone in CTD-Associated Pulmonary Arterial Hypertension Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedExpanded the Locations section to include a comprehensive global list of study sites across the United States and multiple countries. The presentation shifted from separate state blocks to a unified, extensive locations list.SummaryDifference3%

- Check21 days agoChange DetectedNo significant changes to the study page were observed in the screenshots.SummaryDifference0.1%

- Check28 days agoChange DetectedThe screenshots show no substantive changes to core study details (title, conditions, outcomes, and eligibility). The page appears unchanged.SummaryDifference0.1%

- Check42 days agoChange DetectedMinor site revision updated from v3.2.0 to v3.3.2; this change does not affect study information or participant-facing content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check50 days agoChange DetectedThe page no longer shows the government funding lapse notice for NIH’s operating status. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check57 days agoChange DetectedNo significant changes were observed on the study details page between the two screenshots.SummaryDifference0.1%

Stay in the know with updates to Bardoxolone in CTD-Associated Pulmonary Arterial Hypertension Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Bardoxolone in CTD-Associated Pulmonary Arterial Hypertension Clinical Trial page.